Innovative Technologies for the Treatment of Pulmonary and Heart Failure

NCT05090930 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Cardiogenic Shock
Ventricular Arrythmia
Cardiac Arrest With Successful Resuscitation
Sepsis
Multiple Organ Failure
Pulmonary Failure
Decompensated Heart Failure
Acute Heart Failure

Interventions

DEVICE: HA330 - Jafron Biomedical Co., Ltd., China - extracorporeal hemocorrection
DEVICE: CytoSorb (CytoSorbents Corp., USA) - an extracorporeal cytokine adsorber

Sponsor

National Research Center for Cardiac Surgery, Kazakhstan

Collaborators

[object Object]